Xenon Pharmaceuticals Inc (NAS:XENE)
$ 40.76 2.12 (5.49%) Market Cap: 3.09 Bil Enterprise Value: 2.38 Bil PE Ratio: 0 PB Ratio: 3.65 GF Score: 49/100

Q1 2023 Xenon Pharmaceuticals Inc Earnings Call Transcript

May 09, 2023 / 08:30PM GMT
Release Date Price: $43.54 (+2.45%)
Operator

Hello, and thank you for standing by. My name is Gigi, and I'll be your conference operator today. At this time, I would like to welcome everyone to the Q1 2023 Xenon Pharmaceuticals Inc. Earnings Conference Call. (Operator Instructions)

I would now like to turn the conference over to Sherry Aulin, Chief Financial Officer. Please go ahead.

Sherry Aulin
Xenon Pharmaceuticals Inc. - CFO

Thank you, and good afternoon, everyone. Thank you for joining us on our call and webcast to discuss the Xenon's First Quarter 2023 Financial and Operating Results. Joining me are: Ian Mortimer, Xenon's President and Chief Executive Officer; Dr. Chris Kenney, Xenon's Chief Medical Officer; and Dr. Chris Von Seggern, Xenon's Chief Commercial Officer.

Ian will open today's call with a summary of our proprietary pipeline programs. Chris Kenney will provide an overview of our XEN1101 Phase 3 epilepsy program, as well as a brief summary of the recent oral presentation of supporting data from the X-TOLE open-label study that was presented at the American Academy of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot